InvestorsHub on MSN

Abivax shares gain after 22 scientific abstracts accepted for ECCO 2026

Abivax SA ADR (NASDAQ:ABVX) shares rose 2.6% in premarket trading on Thursday after the clinical-stage biotechnology company announced that 22 scientific abstracts have been accepted for presentation ...

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on Preclinical Anti-Fibrotic Findings

Abivax Announces Acceptance of 22 Abstracts Evaluating Obefazimod in Inflammatory Bowel Disease at ECCO 2026, Featuring an Oral Presentation on ...

OmniAb, Inc. (OABI) Discusses Launch and Scientific Overview of OmniUltra Technology Platform Transcript

Discusses Launch and Scientific Overview of OmniUltra Technology Platform December 15, 2025 5:00 PM ESTCompany ...